OrbusNeich Medical called the cops on Boston Scientific in Germany in a nasty escalation of their ongoing stent patent dispute.
The lengthy patent dispute between Medtronic and Boston Scientific will end in the nation's highest courtroom, as the Supreme Court has agreed to hear Medtronic's plea to avoid paying cardiac device royalties.
Vascular Solutions is suing Boston Scientific, claiming the company's Guidezilla extension catheter infringes on its patents and asking a Minnesota court to hault the device's sale.
Boston Scientific enrolled its first patient in a study of its self-expanding WallFlex Biliary RX Stent to broaden the indication of the device for the purposes of draining bile before pancreatic cancer surgery.
OrbusNeich Medical accuses Boston Scientific of using a U.K. subsidiary to circumvent a preliminary court injunction in Germany that prevented the sale of some of its stents at the center of a patent dispute between the two companies.
Boston Scientific CEO Michael Mahoney predicts a long-awaited return to growth for the company in the second half of 2013, driven largely by five new products acquired through acquisitions. And Watchmen may have the biggest expectations behind it of the bunch.
Boston Scientific's Watchman is more effective in preventing stroke than standard-of-care warfarin, according to a study, giving the company some renewed hope for the device's FDA approval and eventual large market leadership.
Nanostim says its tiny wireless cardiac pacemaker has shown some success in its first three human patients, early signs that the potentially disruptive technology has legs. And the company's advance, presented this week at the Heart Rhythm Society meeting in Denver, may give it the lead over larger medical device rivals trying to come up with something similar.
Germany's Biotronik won the FDA's sign-off for its Ilesto line of cardioverter-defibrillator/cardiac resynchronization therapy defibrillators (ICD/CRT-D).
Medtronic's U.S. launch this week of a new cardiac resynchronization therapy device triggered a nasty advertising battle with arch-rival Boston Scientific.